1 completed, 1 recruiting, 1 terminated. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 1, Recruiting 1, Terminated 1 |
Follow CellSeed Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase III Study of CLS2901C in Patients With Osteoarthritis of the Knee CLS2901C (human [allogeneic] chondrocyte sheets) - Osteoarthritis of the Knee | Phase 3 | Recruiting | CellSeed Inc. | 96 | 2023-10-20 | 2026-07-09 |
| A Study to Evaluate the Esophageal Stenosis Inhibition Effects of CLS2702C/CLS2702D After Endoscopic Submucosal Dissection (ESD) in Patients With Superficial Esophageal Cancer in the Steroid Administration Risk Group CLS2702C/CLS2702D - Superficial Esophageal Cancer | Phase 3 | Terminated | CellSeed Inc. | 1 | 2021-02-04 | 2026-03-27 |
| Human (Autologous) Oral Mucosal Cell Sheet Transplantation After ESD in Patients With Superficial Esophageal Cancer CLS2702C/CLS2702D - Superficial Esophageal Cancer | Phase 3 | Completed | CellSeed Inc. | 10 | 2016-04-01 | 2019-03-07 |
Japan (3)
Manabu Ishizuka (1)